Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy
Clinical trial NCT04465760 · TERMINATED
Trial details
- NCT number
- NCT04465760
- Sponsor
- OHSU Knight Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-25
- Primary completion
- 2021-10-05
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.